萨瓦拉制药 SVRA
$4.83 +$0.45 (+10.27%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $4.90 +1.45%
开盘$4.46
昨收$4.38
当日区间$4.41 – $4.90
成交量2.23M
市值$992.37M
市盈率（TTM）–
股息率–
SVRA 相关新闻
匹配 Savara 或代码 SVRA 的头条新闻，按最新排序。
- Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16
- Guggenheim Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $11
- LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10
- A Quick Look at Today's Ratings for Savara(SVRA.US), With a Forecast Between $9 to $11
- Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $11
- H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10
- Wells Fargo Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9
- LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Raises Target Price to $10 正面
- LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9
- A Quick Look at Today's Ratings for Savara(SVRA.US), With a Forecast Between $9 to $16
- Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Raises Target Price to $11 正面
- LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Cuts Target Price to $9 负面
- LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $11
- H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10
- Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16
暂无评论——快来第一个聊聊 SVRA。
登录后参与讨论。